Less invasive method for determining stage of lung cancer shows benefits

November 23, 2010

A comparison of two strategies to determine the stage of suspected non-small cell lung cancer (NSCLC) finds that the less invasive method is more effective at identifying a type of lung cancer that has spread, and may result in a reduction of unnecessary surgical procedures and associated adverse effects for certain patients, according to a study in the November 24 issue of JAMA.

Lung cancer is the most commonly diagnosed cancer worldwide (1.35 million/year) and also the most frequent cause of cancer death (1.2 million/year). Determining the stage of cancer is an important part of patient care because staging directs therapy and has prognostic value, according to background information in the article. But determining the stage via surgery has limitations and may result in unnecessary thoracotomies (incision into the chest cavity), which may result in significantly impaired health following the surgery, and a higher risk of death.

Current lung cancer staging guidelines acknowledge endosonography (ultrasound of internal organs with the use of a fiberoptic endoscope) as a minimally invasive alternative to surgical staging to detect nodal (collection of tissue) disease, followed by surgical staging (if no nodal metastases are found by endosonography). Mediastinal (space in the thoracic cavity near the lungs) tissue staging is usually performed by mediastinoscopy, a surgical diagnostic procedure. "At present it is not known whether initial mediastinal tissue staging of lung cancer by endosonography improves the detection of nodal metastases and reduces the rate of unnecessary thoracotomies," the authors write.

Jouke T. Annema, M.D., Ph.D., of the Leiden University Medical Center, Leiden, the Netherlands, and colleagues compared surgical staging alone vs. endosonography (combined transesophageal and endobronchial ultrasound) followed by surgical staging. The randomized controlled multicenter trial, conducted between February 2007 and April 2009, included 241 patients with resectable (suspected) NSCLC in whom mediastinal staging was indicated based on computed or positron emission tomography (imaging techniques). Patients received either surgical staging or endosonography followed by surgical staging in case no nodal metastases were found at endosonography. Thoracotomy with lymph node dissection was performed when there was no evidence of mediastinal tumor spread.

Of the 241 patients who were randomized, 118 received surgical staging and 123 endosonography, of whom 65 also underwent surgical staging. "Nodal metastases were found in 41 patients (35 percent) by surgical staging vs. 56 patients (46 percent) by endosonography and in 62 patients (50 percent) by endosonography followed by surgical staging. This corresponded to sensitivities of 79 percent (41/52) vs. 85 percent (56/66) and 94 percent (62/66)," the authors write.

The number of unnecessary thoracotomies was 21 of 118 (18 percent) in the surgical staging vs. 9 of 123 (7 percent) in the endosonography group. There was no difference in the complication rate between the 2 groups, with complications occurring in 7 of 118 (6 percent) in the surgical staging vs. 6 of 123 (5 percent) in the endosonography group.

"We have shown that commencing mediastinal nodal staging with endosonography significantly improves the detection of nodal metastases and reduces the rate of unnecessary thoracotomies by more than half compared with surgical staging alone, in patients with resectable NSCLC," the authors write. "Furthermore, endosonography does not require general anesthesia, is preferred by patients, and is considered cost-effective compared with surgical staging."

The researchers add that given that the sensitivity of endosonography is similar to that of mediastinoscopy (85 percent vs. 79 percent, respectively), and that endosonography is associated with a lower complication rate (1 percent vs. 6 percent for mediastinoscopy), endosonography should be the first step for mediastinal nodal staging.

(JAMA. 2010;304[20]:2245-2252. Available pre-embargo to the media at www.jamamedia.org)

Editor's Note: Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.






Editorial: Staging Strategies for Lung Cancer

In an accompanying editorial, Mark D. Iannettoni, M.D., M.B.A., of the University of Iowa Hospitals and Clinics, Iowa City, writes that an important factor regarding the use of endoscopic procedures is the level of expertise of the operator.

"Even though this emerging technology of endoscopic study can result in excellent results for predicting both positive and now improved negative results, highly skilled interventionalists are required to provide these exceptional outcomes. ... Until this modality can be reproduced at all centers where thoracic surgery is commonly performed, or until all of these patients are cared for at specialized centers, surgical staging must remain the gold standard for adequate preoperative evaluation."

(JAMA. 2010;304[20]:2296-2297. Available pre-embargo to the media at www.jamamedia.org)

Editor's Note: Please see the article for additional information, including financial disclosures, funding and support, etc.
-end-
To contact Jouke T. Annema, M.D., Ph.D., email j.t.annema@lumc.nl. To contact editorial author Mark D. Iannettoni, M.D., M.B.A., call Tom Moore at 319-356-3945 or email thomas-moore@uiowa.edu.

For More Information: Contact the JAMA/Archives Media Relations Department at 312-464-JAMA or email: mediarelations@jama-archives.org.

The JAMA Network Journals

Related Lung Cancer Articles from Brightsurf:

State-level lung cancer screening rates not aligned with lung cancer burden in the US
A new study reports that state-level lung cancer screening rates were not aligned with lung cancer burden.

The lung microbiome may affect lung cancer pathogenesis and prognosis
Enrichment of the lungs with oral commensal microbes was associated with advanced stage disease, worse prognosis, and tumor progression in patients with lung cancer, according to results from a study published in Cancer Discovery, a journal of the American Association for Cancer Research.

New analysis finds lung cancer screening reduces rates of lung cancer-specific death
Low-dose CT screening methods may prevent one death per 250 at-risk adults screened, according to a meta-analysis of eight randomized controlled clinical trials of lung cancer screening.

'Social smokers' face disproportionate risk of death from lung disease and lung cancer
'Social smokers' are more than twice as likely to die of lung disease and more than eight times as likely to die of lung cancer than non-smokers, according to research presented at the European Respiratory Society International Congress.

Lung cancer therapy may improve outcomes of metastatic brain cancer
A medication commonly used to treat non-small cell lung cancer that has spread, or metastasized, may have benefits for patients with metastatic brain cancers, suggests a new review and analysis led by researchers at St.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Lung transplant patients face elevated lung cancer risk
In an American Journal of Transplantation study, lung cancer risk was increased after lung transplantation, especially in the native (non-transplanted) lung of single lung transplant recipients.

Proposed cancer treatment may boost lung cancer stem cells, study warns
Epigenetic therapies -- targeting enzymes that alter what genes are turned on or off in a cell -- are of growing interest in the cancer field as a way of making a cancer less aggressive or less malignant.

Are you at risk for lung cancer?
This question isn't only for people who've smoked a lot.

Read More: Lung Cancer News and Lung Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.